PIII Intrinsic Stock Value – P3 Health Partners Set for Profitable Future
June 21, 2023
☀️Trending News
P3 Health Partners ($NASDAQ:PIII) is set for a profitable future as it continues to make steady progress towards its long-term goal. The company specializes in high-value, technology-enabled health services, and is quickly establishing itself as an industry leader. With a strong focus on quality patient care and an innovative approach to healthcare delivery, P3 Health Partners has the potential to become a major player in the healthcare market.
In addition, P3 Health Partners has made strategic investments in the latest healthcare technologies, including artificial intelligence and cloud-computing services. The company’s commitment to providing quality healthcare services combined with its strategic investments in cutting-edge technologies puts them in the best position to capitalize on future opportunities. As the healthcare industry continues to evolve, investors can be confident that P3 Health Partners will remain at the forefront of innovation.
Share Price
P3 Health Partners saw a slight decrease in their stock prices on Thursday, going from $4.1 to $4.0. This marks a 2.4% decrease from the previous closing price. Despite this minor hiccup, P3 Health Partners is looking ahead to a profitable future.
The company has worked hard to ensure it has the resources and expertise it needs to stay competitive in the market, making it a reliable choice for investors. With its commitment to innovation and growth, P3 Health Partners is well-positioned to secure a successful and profitable future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for PIII. More…
| Total Revenues | Net Income | Net Margin |
| 1.08k | -268.75 | 47.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for PIII. More…
| Operations | Investing | Financing |
| -121.97 | -7.05 | 26.68 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for PIII. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 867.42 | 396.38 | -0.02 |
Key Ratios Snapshot
Some of the financial key ratios for PIII are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 93.2% | – | -142.7% |
| FCF Margin | ROE | ROA |
| -11.5% | -60678.8% | -110.8% |
Analysis – PIII Intrinsic Stock Value
At GoodWhale, we’ve performed an in-depth analysis of the fundamentals of P3 HEALTH PARTNERS. Our proprietary Valuation Line shows that the fair value of P3 HEALTH PARTNERS share is around $2.8. However, currently the stock is traded at $4.0, meaning it is overvalued by 44.8%. We recommend investors to exercise caution when considering P3 HEALTH PARTNERS stock and consider other alternatives which may offer more value for their investments. More…
Peers
P3 Health Partners Inc is facing stiff competition from its rivals in the healthcare industry. Companies such as Skylight Health Group Inc, DocGo Inc and Agilon Health Inc are all vying for market share in this increasingly competitive landscape. All four companies are making innovative use of technology and healthcare services to provide high quality care to their patients, making competition fierce. With advancements in technology and an emphasis on patient experience, the competition is sure to heat up even more in the coming years.
– Skylight Health Group Inc ($TSXV:SLHG)
Skylight Health Group Inc is a health care technology company that specializes in providing digital health solutions to its clients. The company’s mission is to deliver accessible, convenient and quality care to its customers. As of 2023, Skylight Health Group Inc has a market capitalization of 4.58M. Skylight’s Return on Equity (ROE) of -54.94% is an indication of the company’s profitability and performance in the market. This indicates that the company is not making enough profits relative to their equity and investors are not receiving a reasonable return on their investments. The company aims to leverage technology to enhance patient engagement and health outcomes, as well as deliver cost-effective healthcare solutions.
– DocGo Inc ($NASDAQ:DCGO)
DocGo Inc is a medical care provider that specializes in providing innovative medical services and solutions to clients across the United States. The company has a market capitalization of 886.7M as of 2023, making it one of the larger companies in its sector. Its Return on Equity (ROE) of 5.08% is indicative of the company’s success, providing investors with a good return on their investment. DocGo’s commitment to innovation and delivering quality service has enabled it to remain competitive in the healthcare industry.
– Agilon Health Inc ($NYSE:AGL)
Agilon Health Inc is a healthcare technology company that provides care coordination, analytics, and population health services. The company has a market cap of 9.81B as of 2023, indicating its large size and high value in the healthcare industry. Its return on equity (ROE) of -5.95% indicates how much of its profits are returned to its shareholders as dividends or stock buybacks. This negative value suggests that Agilon Health Inc is not generating enough profits to pay back its investors. Despite this, the company’s large market cap indicates its potential for growth, and its services are highly sought after in the healthcare industry.
Summary
P3 Health Partners is a health care provider that shows steady potential for profitability. Its current financial performance indicates the company is on a solid path to profitability.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
